The areas under the ROC curves (AUCs) obtained in our analysis indicated a high diagnostic sensitivity of NF-L concentration measurements in the assessment of neuropathy among breast cancer patients treated with paclitaxel in NAC therapy. The gene discussed is NEFL; the disease is breast carcinoma.